Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Our nurses will tell you exactly what to expect based on your situation, including how this formula compares to our other injectable and IV options
No direct interaction is known, but excessive alcohol may reduce overall health benefits
It can make a difference in the lives of those who rely on plasma-derived therapies
Discuss self-pay alternatives with your prescriber
Barriers to effective treatment include the persistent stigma that Medication-Assisted Treatment (MAT) is simply trading one drug for another, despite its reducing harm
By extrapolation from the established profiles of approved GLP-1 receptor agonists including semaglutide (Wegovy SmPC, MHRA/EMC) and tirzepatide (Mounjaro SmPC, MHRA/EMC) clinicians should anticipate the need to review and potentially reduce antihypertensive doses as significant weight loss occurs, in line with BNF and NICE guidance principles
US$ 23.08
US$ 24.47
US$ 26.87
US$ 28.22
